| Product Code: ETC343161 | Publication Date: Aug 2022 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, China import shipments of pulmonary/respiratory drug delivery products continued to show high concentration, with the top exporting countries being Puerto Rico, Metropolitan France, Germany, Spain, and Italy. Despite a negative Compound Annual Growth Rate (CAGR) of -2.06% from 2020 to 2024, the growth rate in 2023-24 saw a significant decline of -26.63%. This indicates a challenging market environment for respiratory drug delivery imports into China, requiring a strategic approach to navigate the evolving landscape.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Pulmonary/ Respiratory Drug Delivery Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, 2021 & 2031F |
3.3 China Pulmonary/ Respiratory Drug Delivery Market - Industry Life Cycle |
3.4 China Pulmonary/ Respiratory Drug Delivery Market - Porter's Five Forces |
3.5 China Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume Share, By Formulations, 2021 & 2031F |
3.6 China Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume Share, By Canister Type, 2021 & 2031F |
3.7 China Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume Share, By Applications, 2021 & 2031F |
3.8 China Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 China Pulmonary/ Respiratory Drug Delivery Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of respiratory diseases in China |
4.2.2 Rising awareness about the importance of pulmonary drug delivery |
4.2.3 Technological advancements in drug delivery devices |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval |
4.3.2 High cost associated with development and commercialization of respiratory drug delivery products |
5 China Pulmonary/ Respiratory Drug Delivery Market Trends |
6 China Pulmonary/ Respiratory Drug Delivery Market, By Types |
6.1 China Pulmonary/ Respiratory Drug Delivery Market, By Formulations |
6.1.1 Overview and Analysis |
6.1.2 China Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Formulations, 2021 - 2031F |
6.1.3 China Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.4 China Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Device Type, 2021 - 2031F |
6.2 China Pulmonary/ Respiratory Drug Delivery Market, By Canister Type |
6.2.1 Overview and Analysis |
6.2.2 China Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Plain Canister, 2021 - 2031F |
6.2.3 China Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Coated Canister, 2021 - 2031F |
6.3 China Pulmonary/ Respiratory Drug Delivery Market, By Applications |
6.3.1 Overview and Analysis |
6.3.2 China Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Asthma, 2021 - 2031F |
6.3.3 China Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By COPD, 2021 - 2031F |
6.3.4 China Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Cystic Fibrosis, 2021 - 2031F |
6.4 China Pulmonary/ Respiratory Drug Delivery Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 China Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Hospitals & Clinics, 2021 - 2031F |
6.4.3 China Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Homecare settings, 2021 - 2031F |
7 China Pulmonary/ Respiratory Drug Delivery Market Import-Export Trade Statistics |
7.1 China Pulmonary/ Respiratory Drug Delivery Market Export to Major Countries |
7.2 China Pulmonary/ Respiratory Drug Delivery Market Imports from Major Countries |
8 China Pulmonary/ Respiratory Drug Delivery Market Key Performance Indicators |
8.1 Adoption rate of advanced pulmonary drug delivery devices |
8.2 Number of clinical trials for respiratory drug delivery products in China |
8.3 Patient adherence and satisfaction with pulmonary drug delivery methods |
9 China Pulmonary/ Respiratory Drug Delivery Market - Opportunity Assessment |
9.1 China Pulmonary/ Respiratory Drug Delivery Market Opportunity Assessment, By Formulations, 2021 & 2031F |
9.2 China Pulmonary/ Respiratory Drug Delivery Market Opportunity Assessment, By Canister Type, 2021 & 2031F |
9.3 China Pulmonary/ Respiratory Drug Delivery Market Opportunity Assessment, By Applications, 2021 & 2031F |
9.4 China Pulmonary/ Respiratory Drug Delivery Market Opportunity Assessment, By End User, 2021 & 2031F |
10 China Pulmonary/ Respiratory Drug Delivery Market - Competitive Landscape |
10.1 China Pulmonary/ Respiratory Drug Delivery Market Revenue Share, By Companies, 2024 |
10.2 China Pulmonary/ Respiratory Drug Delivery Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |